Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Jul 15, 2020; 12(7): 782-790
Published online Jul 15, 2020. doi: 10.4251/wjgo.v12.i7.782
Published online Jul 15, 2020. doi: 10.4251/wjgo.v12.i7.782
Figure 1 Disease-free and overall survival rates in the conventional adjuvant chemotherapy group and hyperthermic intraperitoneal perfusion group.
A: Disease-free survival rates; B: Overall survival rates. HIPEC: Hyperthermic intraperitoneal perfusion.
- Citation: Xie TY, Wu D, Li S, Qiu ZY, Song QY, Guan D, Wang LP, Li XG, Duan F, Wang XX. Role of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer. World J Gastrointest Oncol 2020; 12(7): 782-790
- URL: https://www.wjgnet.com/1948-5204/full/v12/i7/782.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i7.782